Metrics as of 10/17/2026, 08:38 AM (Berlin time), refresh in progress.
Medline Stock
Medline Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Country
- United States
- CEO
- James Boyle
- Employees
- 45,000
- Market cap
- $31.5 B
- IPO
- 17/12/2025
Medline Inc. is a global manufacturer of medical and surgical products catering to a broad spectrum of healthcare providers. The company's clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes both domestically and worldwide. Established in 1966, Medline…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Medline stock: price history
1D
-1.7%
1W
-0.8%
1M
+9.0%
6M
-24.5%
YTD
-14.4%
1Y
–
2Y
–
5Y
–
10Y
–
Next earnings date
Next earnings date
04/11/2026 (in 18 days)
Volatility around earnings
~67% stronger price swings than usual
Medline stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Ask the agents about Medline
Analyst assessment of Medline
PRICE TARGET LOW
US$37.00
CONSENSUS
US$44.11
MEDIAN
US$43.00
PRICE TARGET HIGH
US$55.00
0
STRONG BUY
15
BUY
2
HOLD
0
SELL
0
STRONG SELL
17
TOTAL · Buy
As of: 09/10/2026
Medline stock metrics
P/E
41.81
P/B
2.66
EV/EBITDA
15.9
RETURN ON EQUITY
0.5%
NET MARGIN
0.8%
DEBT/EQUITY
1.09
DIVIDEND YIELD
0.0%
AS OF
27/06/2026
Free float & liquidity
FREE FLOAT
58.1%
FLOAT SHARES
509,792,811
AVG. DAILY VOLUME (30D)
8,326,162
Insider transactions (SEC)
GIC Private Ltd
GIC Private Ltd
GIC Private Ltd
GIC Private Ltd
GIC Private Ltd
Institutional holders
Smart Money
Register for free
Register now to see which funds are invested
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Comparable stocks
Frequently asked questions about Medline stock
What does Medline do?
Medline Inc. is a company in the Healthcare sector, Medical - Instruments & Supplies industry, headquartered in United States.
The CEO is James Boyle, the company employs around 45,000 people.
The IPO was on 17/12/2025; the stock trades on NASDAQ under the ticker MDLN.
What do analysts say about Medline stock?
17 analysts rate the stock, the consensus is Buy (as of 09/10/2026).
The average price target is US$44.11, ranging from US$37.00 to US$55.00, with a median of US$43.00.
This is an external assessment, not a statement by Market Jury.
When does Medline report next?
The next earnings date is 04/11/2026.
Around past earnings, price swings were roughly 67% stronger than usual.
Does Medline pay a dividend?
No, Medline currently does not pay a dividend.
Which stocks are comparable to Medline?
Comparable stocks include Intuitive Surgical, Becton, Dickinson and Company, ResMed, West Pharmaceutical Services, Solventum, Baxter International, Cooper Companies and Avantor.
How can I get Medline stock analyzed?
Clicking "Analyze stock" lets five strategies assess Medline against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.